Microbion Finds $25M For Treating Infections

Bozeman, Montana- and Vancouver, British Columbia-based Microbion Corporation, a developer of biopharmaceuticals aimed at treating hard to treat and antibiotic-resistant infections, has raised $25M in a funding round

The story you have requested is only available to paid members of the web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.